135 related articles for article (PubMed ID: 26346258)
1. Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer.
Kato Y; Ochiai K; Michishita M; Azakami D; Nakahira R; Morimatsu M; Ishiguro-Oonuma T; Yoshikawa Y; Kobayashi M; Bonkobara M; Kobayashi M; Takahashi K; Watanabe M; Omi T
Vet J; 2015 Nov; 206(2):143-8. PubMed ID: 26346258
[TBL] [Abstract][Full Text] [Related]
2. Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines.
Kato Y; Ochiai K; Kawakami S; Nakao N; Azakami D; Bonkobara M; Michishita M; Morimatsu M; Watanabe M; Omi T
BMC Vet Res; 2017 Jun; 13(1):170. PubMed ID: 28599655
[TBL] [Abstract][Full Text] [Related]
3. The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α.
Azakami D; Nakahira R; Kato Y; Michishita M; Kobayashi M; Onozawa E; Bonkobara M; Kobayashi M; Takahashi K; Watanabe M; Ishioka K; Sako T; Ochiai K; Omi T
Vet Comp Oncol; 2017 Jun; 15(2):557-562. PubMed ID: 26762899
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.
Ochiai K; Morimatsu M; Kato Y; Ishiguro-Oonuma T; Udagawa C; Rungsuriyawiboon O; Azakami D; Michishita M; Ariyoshi Y; Ueki H; Nasu Y; Kumon H; Watanabe M; Omi T
Oncotarget; 2016 Jan; 7(3):3283-96. PubMed ID: 26658102
[TBL] [Abstract][Full Text] [Related]
5. Subdomain structure of the co-chaperone SGTA and activity of its androgen receptor client.
Trotta AP; Need EF; Butler LM; Selth LA; O'Loughlin MA; Coetzee GA; Tilley WD; Buchanan G
J Mol Endocrinol; 2012 Oct; 49(2):57-68. PubMed ID: 22693264
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation.
Trotta AP; Need EF; Selth LA; Chopra S; Pinnock CB; Leach DA; Coetzee GA; Butler LM; Tilley WD; Buchanan G
Int J Cancer; 2013 Dec; 133(12):2812-23. PubMed ID: 23740762
[TBL] [Abstract][Full Text] [Related]
7. Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.
Butler MS; Yang X; Ricciardelli C; Liang X; Norman RJ; Tilley WD; Hickey TE
Fertil Steril; 2013 Jun; 99(7):2076-83.e1. PubMed ID: 23433514
[TBL] [Abstract][Full Text] [Related]
8. The cochaperone SGTA (small glutamine-rich tetratricopeptide repeat-containing protein alpha) demonstrates regulatory specificity for the androgen, glucocorticoid, and progesterone receptors.
Paul A; Garcia YA; Zierer B; Patwardhan C; Gutierrez O; Hildenbrand Z; Harris DC; Balsiger HA; Sivils JC; Johnson JL; Buchner J; Chadli A; Cox MB
J Biol Chem; 2014 May; 289(22):15297-308. PubMed ID: 24753260
[TBL] [Abstract][Full Text] [Related]
9. Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation.
Lallous N; Leblanc E; Munuganti RS; Hassona MD; Nakouzi NA; Awrey S; Morin H; Roshan-Moniri M; Singh K; Lawn S; Yamazaki T; Adomat HH; Andre C; Daugaard M; Young RN; Guns ES; Rennie PS; Cherkasov A
Mol Cancer Ther; 2016 Dec; 15(12):2936-2945. PubMed ID: 27765852
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.
Butler MS; Ricciardelli C; Tilley WD; Hickey TE
Horm Cancer; 2013 Jun; 4(3):154-64. PubMed ID: 23443946
[TBL] [Abstract][Full Text] [Related]
11. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD
Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
13. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and functional characterization of the canine androgen receptor.
Lu B; Smock SL; Castleberry TA; Owen TA
Mol Cell Biochem; 2001 Oct; 226(1-2):129-40. PubMed ID: 11768233
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical role of small glutamine-rich tetratricopeptide repeat (TPR)-containing protein alpha (SGTA) as a novel cell cycle protein in NSCLC.
Xue Q; Lv L; Wan C; Chen B; Li M; Ni T; Liu Y; Liu Y; Cong X; Zhou Y; Ni R; Mao G
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1539-49. PubMed ID: 23857189
[TBL] [Abstract][Full Text] [Related]
16. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
[TBL] [Abstract][Full Text] [Related]
17. Immunostaining of the androgen receptor and sequence analysis of its DNA-binding domain in canine prostate cancer.
Lai CL; van den Ham R; Mol J; Teske E
Vet J; 2009 Sep; 181(3):256-60. PubMed ID: 18583166
[TBL] [Abstract][Full Text] [Related]
18. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
Lu Y; Feng F; Yang Y; Gao X; Cui J; Zhang C; Zhang F; Xu Z; Qv J; Wang C; Zeng Z; Zhu Y; Yang Y
Cell Signal; 2013 Feb; 25(2):479-89. PubMed ID: 23153584
[TBL] [Abstract][Full Text] [Related]
19. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
20. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]